-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
Dendreon Jumps 40% on Provenge Sales
Dendreon saw its stock jump Thursday as sales of its cancer drug beat the expectations of both analysts and the company itself.
Teva’s New CEO Is Battle-Tested. Good Thing
Drug industry vet Jeremy Levin earned his stripes making deals for Bristol-Myers Squibb, but he'll face tough going at the generic-drug maker.
Mead Johnson Bounce Followed J&J Script
Mead Johnson's recent Enfamil scare sent many investors packing -- but those who stuck with the stock could soon be rewarded.
FDA, Insurers Demand Tests for New Drugs
Pressure on pharmaceutical companies for evidence that their drugs work is fueling a surge in the global market for "companion diagnostics."
7 Biotech and Health Care Stocks to Buy
Biotechnology and health care companies are growing at an alarming rate. Do not miss the boat on some of fastest-growing companies among them.
Acquisitions, Strong Sales Keep Pfizer Dividend Strong
Despite stagnant revenue growth, good operating margins for Pfizer (NYSE:PFE) leaves room for cash-generating dividends for investors.
Ariad Pharmaceuticals Still Might Have Upside
Ariad Pharmaceuticals is up 120% in the past 12 months, mostly fueled on optimism over its trial leukemia treatment. But some analysts think the ceiling is higher.
Amgen CEO Says ‘I’m Leaving.’ Investors Say ‘Good Riddance’
After a decade as CEO, the oft-maligned Kevin Sharer will step down. That's giving shareholders holiday cheer as they bid the stock up on the news.
Amgen Getting Its Groove Back
As its CEO steps down, Amgen stock is breaking out. See the target for AMGN.
Researcher: J&J/Pharmacyclics Drug Could Be a Game-Changer
The experimental cancer drug Johnson & Johnson bought last week is receiving high praise, and could be "paradigm-shifting."
Covidien Follows Abbott With a Pharma Spin-Off
Could Sanofi, Novartis or GlaxoSmithKline be next to separate pharmaceutical development into a stand-alone company?
7 Feel-Good Pharma Stocks to Buy
Medicine is something few people can afford to go without during times of recession, making these pharma companies good sources of stability.
Pfizer Delivers Early Holiday Gifts to Shareholders
The company brings holiday cheer with its new stock repurchase program and dividend boost.
Abbott Labs Spinoff Looks Like the Right Move
Shareholders would likely be better served by the company's prescription drug business standing alone. Here's why.
Why Eli Lilly Could Be a Lottery Stock Pick
If Eli Lilly is successful in delaying the progression of Alzheimer’s disease with its experimental drug, it could make Lipitor look like a mid-sized product. The odds?
5 Small-Cap Buys With Large Potential
Small cap stocks can be very risky, but very rewarding. These 5 do everything from mining to groceries -- and they can deliver big profits.
10 Game-Changing Health Care Stocks to Buy
These 10 diverse stocks are likely to improve their earnings and stock prices in 2012. Take a look.
Top 5 Emerging Growth Stocks for December
Louis Navellier's top five emerging growth stocks for December include standouts such as Jazz Pharmaceuticals and Hansen Natural Corp.
Affymax Shares Hang on an FDA Decision
Affymax's stock price is swinging wildly as investors await a ruling on the company's promising kidney disease drug.
